iPSC Lines: iPSC Control Lines From Healthy Donors
At Applied StemCell, we specialize in providing high-quality induced Pluripotent Stem Cell (iPSC) lines that are crucial for advanced research in stem cell biology and regenerative medicine. Our iPSC lines are designed to support cutting-edge research and therapeutic development.
Types of iPSC Lines Offered
Healthy Control iPSC Lines
Our healthy iPSC lines are derived from well-characterized donors with all the required documenation, offering a reliable model for various research applications and therapeutic developments.
Hypoimmunogenic iPSCs
We also offer engineered hypoimmunogenic iPSCs—ActiCells™ RUO Hypo hiPSCs—for early cell therapy development, with a GMP matching line coming soon.
Benefits of Using Applied StemCell’s iPSC Lines
Our iPSC lines are of high quality with rigorous QC testing and documentation, providing researchers with reliable results. We offer customizable solutions to meet specific project requirements, supported by our team of experts who provide reliable support and expertise.
- Footprint-free iPSC cells (episomal and other integration-free methods) and retroviral-reprogrammed iPSCs
- Characterized for pluripotency markers, karyotyping, and differentiation potential; more characterization options are available
- Multiple donor tissues: PBMCs, fibroblasts, cord blood, adipocytes from healthy and diseased patients
- Tested for CRISPR genome editing and differentiation potential into various cell lineages
- Ideal as master iPSC cell lines to build engineered and/or panels of differentiated isogenic cell lineages
Customizable Services
Applied StemCell offers tailored iPSC differentiation protocols to fit your unique research needs. Whether you require specific differentiation or genetic modifications, we provide the flexibility to ensure your project’s success.
Fast Turnaround
We understand the importance of timely delivery. Our efficient processing ensures quick turnaround times, allowing you to stay on schedule with your research projects. Case studies demonstrate our ability to deliver high-quality cells rapidly.